{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:34:29Z","timestamp":1790775269717,"version":"4.1.0"},"publisher-location":"Cham","reference-count":80,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030624514","type":"print"},{"value":"9783030624521","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,6,23]],"date-time":"2018-06-23T00:00:00Z","timestamp":1529712000000},"content-version":"vor","delay-in-days":173,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Contact with the skin is inevitable or desirable for daily life products such as cosmetics, hair dyes, perfumes, drugs, household products, and industrial and agricultural products. Whereas the majority of these products are harmless, a number can become metabolized and\/or activate the immunological defense via innate and adaptive mechanisms resulting in sensitization and allergic contact dermatitis upon following exposures to the same substance. Therefore, strict safety (hazard) assessment of actives and ingredients in products and drugs applied to the skin is essential to determine I) whether the chemical is a potential sensitizer and if so II) what is the safe concentration for human exposure to prevent sensitization from occurring. Ex vivo skin is a valuable model for skin penetration studies but due to logistical and viability limitations the development of in vitro alternatives is required. The aim of this review is to give a clear overview of the organotypic in vitro skin models (reconstructed human epidermis, reconstructed human skin, immune competent skin models incorporating Langerhans Cells and T-cells, skin-on-chip) that are currently commercially available or which are being used in a laboratory research setting for hazard assessment of potential sensitizers and for investigating the mechanisms (sensitization key events 1\u20134) related to allergic contact dermatitis. The limitations of the models, their current applications, and their future potential in replacing animals in allergy-related science are discussed.<\/jats:p>","DOI":"10.1007\/82_2018_88","type":"book-chapter","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T03:48:12Z","timestamp":1529639292000},"page":"103-129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Progress on Reconstructed Human Skin Models for Allergy Research and Identifying Contact Sensitizers"],"prefix":"10.1007","author":[{"given":"Charlotte","family":"Rodrigues Neves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,23]]},"reference":[{"issue":"3","key":"88_CR1","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1039\/C4LC00999A","volume":"15","author":"HE Abaci","year":"2015","unstructured":"Abaci HE et al (2015) Pumpless microfluidic platform for drug testing on human skin equivalents. Lab Chip 15(3):882\u2013888","journal-title":"Lab Chip"},{"issue":"14","key":"88_CR2","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/adhm.201500936","volume":"5","author":"HE Abaci","year":"2016","unstructured":"Abaci HE et al (2016) Human skin constructs with spatially controlled vasculature using primary and iPSC-derived endothelial cells. Adv Healthcare Mat 5(14):1800\u20131807","journal-title":"Adv Healthcare Mat"},{"issue":"2","key":"88_CR3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000265681","volume":"23","author":"K Ackermann","year":"2010","unstructured":"Ackermann K et al (2010) The Phenion full-thickness skin model for percutaneous absorption testing. Skin Pharmacol Physiol 23(2):105\u2013112","journal-title":"Skin Pharmacol Physiol"},{"issue":"4","key":"88_CR4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/15476910600978038","volume":"3","author":"N Ade","year":"2006","unstructured":"Ade N et al (2006) Activation of U937 cells by contact sensitizers: CD86 expression is independent of apoptosis. J Immunotoxicol 3(4):189\u2013197","journal-title":"J Immunotoxicol"},{"key":"88_CR5","doi-asserted-by":"crossref","unstructured":"Ahadian S, et al (2017) Organ-on-a-chip platforms: a convergence of advanced materials, cells, and microscale technologies. Adv Healthc Mater","DOI":"10.1002\/adhm.201700506"},{"issue":"5","key":"88_CR6","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.tiv.2014.04.007","volume":"28","author":"M Alloul-Ramdhani","year":"2014","unstructured":"Alloul-Ramdhani M, Tensen CP, El Ghalbzouri A (2014) Performance of the N\/TERT epidermal model for skin sensitizer identification via Nrf2-Keap1-ARE pathway activation. Toxicol In Vitro 28(5):982\u2013989","journal-title":"Toxicol In Vitro"},{"issue":"3","key":"88_CR7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.tiv.2010.12.014","volume":"25","author":"N Andreas","year":"2011","unstructured":"Andreas N et al (2011) The intra- and inter-laboratory reproducibility and predictivity of the KeratinoSens assay to predict skin sensitizers in vitro: results of a ring-study in five laboratories. Toxicol In Vitro 25(3):733\u2013744","journal-title":"Toxicol In Vitro"},{"issue":"2","key":"88_CR8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/ics.12355","volume":"39","author":"E Andres","year":"2017","unstructured":"Andres E et al (2017) Preliminary performance data of the RHE\/IL-18 assay performed on SkinEthic RHE for the identification of contact sensitizers. Int J Cosmet Sci 39(2):121\u2013132","journal-title":"Int J Cosmet Sci"},{"issue":"4","key":"88_CR9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3109\/15569527.2014.979425","volume":"34","author":"AM Api","year":"2015","unstructured":"Api AM, Basketter D, Lalko J (2015) Correlation between experimental human and murine skin sensitization induction thresholds. Cutaneous Ocular Toxicol 34(4):298\u2013302","journal-title":"Cutaneous Ocular Toxicol"},{"issue":"5","key":"88_CR10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.tiv.2005.10.012","volume":"20","author":"T Ashikaga","year":"2006","unstructured":"Ashikaga T et al (2006) Development of an in vitro skin sensitization test using human cell lines: the human cell line activation test (h-CLAT) I. Optimization of the h-CLAT protocol. Toxicol In Vitro 20(5):767\u2013773","journal-title":"Toxicol In Vitro"},{"issue":"18","key":"88_CR11","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1039\/c3lc50227a","volume":"13","author":"B Atac","year":"2013","unstructured":"Atac B et al (2013) Skin and hair on-a-chip: in vitro skin models versus ex vivo tissue maintenance with dynamic perfusion. Lab Chip 13(18):3555\u20133561","journal-title":"Lab Chip"},{"issue":"1","key":"88_CR12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/DER.0000000000000003","volume":"25","author":"DA Basketter","year":"2014","unstructured":"Basketter DA et al (2014) Categorization of chemicals according to their relative human skin sensitizing potency. Dermatitis 25(1):11\u201321","journal-title":"Dermatitis"},{"key":"88_CR13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tiv.2017.09.019","volume":"46","author":"S Bock","year":"2017","unstructured":"Bock S et al (2017) Characterization of reconstructed human skin containing Langerhans cells to monitor molecular events in skin sensitization. Toxicol In Vitro 46:77\u201385","journal-title":"Toxicol In Vitro"},{"issue":"5","key":"88_CR14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.tiv.2009.04.005","volume":"23","author":"E Corsini","year":"2009","unstructured":"Corsini E et al (2009) Use of IL-18 production in a human keratinocyte cell line to discriminate contact sensitizers from irritants and low molecular weight respiratory allergens. Toxicol In Vitro 23(5):789\u2013796","journal-title":"Toxicol In Vitro"},{"issue":"3","key":"88_CR15","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.tiv.2012.05.018","volume":"27","author":"E Corsini","year":"2013","unstructured":"Corsini E et al (2013) NCTC 2544 and IL-18 production: a tool for the identification of contact allergens. Toxicol In Vitro 27(3):1127\u20131134","journal-title":"Toxicol In Vitro"},{"issue":"4","key":"88_CR16","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.tiv.2015.02.012","volume":"29","author":"F Cottrez","year":"2015","unstructured":"Cottrez F et al (2015) Genes specifically modulated in sensitized skins allow the detection of sensitizers in a reconstructed human skin model. Development of the SENS-IS assay. Toxicol In Vitro 29(4):787\u2013802","journal-title":"Toxicol In Vitro"},{"key":"88_CR17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tiv.2016.01.007","volume":"32","author":"F Cottrez","year":"2016","unstructured":"Cottrez F et al (2016) SENS-IS, a 3D reconstituted epidermis based model for quantifying chemical sensitization potency: reproducibility and predictivity results from an inter-laboratory study. Toxicol In Vitro 32:248\u2013260","journal-title":"Toxicol In Vitro"},{"issue":"12","key":"88_CR18","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.4049\/jimmunol.176.12.7232","volume":"176","author":"TD de Gruijl","year":"2006","unstructured":"de Gruijl TD et al (2006) A postmigrational switch among skin-derived dendritic cells to a macrophage-like phenotype is predetermined by the intracutaneous cytokine balance. J Immunol 176(12):7232\u20137242","journal-title":"J Immunol"},{"issue":"8","key":"88_CR19","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1021\/tx200196s","volume":"24","author":"T Delaine","year":"2011","unstructured":"Delaine T et al (2011) Structure-Activity Relationship between the in vivo skin sensitizing potency of analogues of phenyl glycidyl ether and the induction of Nrf2-dependent luciferase activity in the keratinosens in vitro assay. Chem Res Toxicol 24(8):1312\u20131318","journal-title":"Chem Res Toxicol"},{"issue":"3","key":"88_CR20","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.taap.2009.02.004","volume":"236","author":"GG dos Santos","year":"2009","unstructured":"dos Santos GG et al (2009) Progress on the development of human in vitro dendritic cell based assays for assessment of the sensitizing potential of a compound. Toxicol Appl Pharmacol 236(3):372\u2013382","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"88_CR21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tiv.2010.10.008","volume":"25","author":"GG dos Santos","year":"2011","unstructured":"dos Santos GG et al (2011) A potential in vitro epidermal equivalent assay to determine sensitizer potency. Toxicol In Vitro 25(1):347\u2013357","journal-title":"Toxicol In Vitro"},{"issue":"1","key":"88_CR22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.0022-202X.2004.23549.x","volume":"124","author":"A El Ghalbzouri","year":"2005","unstructured":"El Ghalbzouri A et al (2005) Basement membrane reconstruction in human skin equivalents is regulated by fibroblasts and\/or exogenously activated keratinocytes. J Invest Dermatol 124(1):79\u201386","journal-title":"J Invest Dermatol"},{"issue":"6","key":"88_CR23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.tiv.2005.03.018","volume":"19","author":"V Facy","year":"2005","unstructured":"Facy V et al (2005) Reactivity of Langerhans cells in human reconstructed epidermis to known allergens and UV radiation. Toxicol In Vitro 19(6):787\u2013795","journal-title":"Toxicol In Vitro"},{"issue":"3","key":"88_CR24","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.tiv.2010.12.011","volume":"25","author":"V Galbiati","year":"2011","unstructured":"Galbiati V et al (2011) Further development of the NCTC 2544 IL-18 assay to identify in vitro contact allergens. Toxicol In Vitro 25(3):724\u2013732","journal-title":"Toxicol In Vitro"},{"key":"88_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2017.01.016","volume":"271","author":"V Galbiati","year":"2017","unstructured":"Galbiati V et al (2017) Development of an in vitro method to estimate the sensitization induction level of contact allergens. Toxicol Lett 271:1\u201311","journal-title":"Toxicol Lett"},{"issue":"2","key":"88_CR26","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/toxsci\/kfh213","volume":"81","author":"GF Gerberick","year":"2004","unstructured":"Gerberick GF et al (2004) Development of a peptide reactivity assay for screening contact allergens. Toxicol Sci 81(2):332\u2013343","journal-title":"Toxicol Sci"},{"key":"88_CR27","doi-asserted-by":"crossref","unstructured":"Gibbs S, et al (2017) Assessment of metal sensitizer potency with the reconstructed human epidermis IL-18 assay. Toxicology","DOI":"10.1016\/j.tox.2017.10.014"},{"issue":"2","key":"88_CR28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2133.2006.07266.x","volume":"155","author":"S Gibbs","year":"2006","unstructured":"Gibbs S et al (2006) Autologous full-thickness skin substitute for healing chronic wounds. Br J Dermatol 155(2):267\u2013274","journal-title":"Br J Dermatol"},{"issue":"2","key":"88_CR29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.taap.2013.07.003","volume":"272","author":"S Gibbs","year":"2013","unstructured":"Gibbs S et al (2013) An epidermal equivalent assay for identification and ranking potency of contact sensitizers. Toxicol Appl Pharmacol 272(2):529\u2013541","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"88_CR30","first-page":"415","volume":"33","author":"F Groeber","year":"2016","unstructured":"Groeber F et al (2016) A first vascularized skin equivalent for as an alternative to animal experimentation. Altex 33(4):415\u2013422","journal-title":"Altex"},{"issue":"5","key":"88_CR31","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0887-2333(02)00039-5","volume":"16","author":"JJ Jacobs","year":"2002","unstructured":"Jacobs JJ et al (2002) An in vitro model for detecting skin irritants: methyl green-pyronine staining of human skin explant cultures. Toxicol In Vitro 16(5):581\u2013588","journal-title":"Toxicol In Vitro"},{"issue":"5","key":"88_CR32","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.tiv.2004.03.007","volume":"18","author":"JJL Jacobs","year":"2004","unstructured":"Jacobs JJL et al (2004) Assessment of contact allergens by dissociation of irritant and sensitizing properties. Toxicol In Vitro 18(5):681\u2013690","journal-title":"Toxicol In Vitro"},{"issue":"6","key":"88_CR33","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.0906-6705.2006.00420.x","volume":"15","author":"JJL Jacobs","year":"2006","unstructured":"Jacobs JJL et al (2006) Skin irritants and contact sensitizers induce Langerhans cell migration and maturation at irritant concentration. Exp Dermatol 15(6):432\u2013440","journal-title":"Exp Dermatol"},{"issue":"2","key":"88_CR34","first-page":"51","volume":"16","author":"S Kano","year":"2011","unstructured":"Kano S et al (2011) Comparison of several reconstructed cultured human skin models by microscopic observation: their usefulness as an alternative membrane for skin in drug permeation experiments. AATEX 16(2):51\u201358","journal-title":"AATEX"},{"key":"88_CR35","doi-asserted-by":"crossref","first-page":"627125","DOI":"10.1155\/2015\/627125","volume":"2015","author":"IJ Kosten","year":"2015","unstructured":"Kosten IJ et al (2015a) Gingiva equivalents secrete negligible amounts of key chemokines involved in langerhans cell migration compared to skin equivalents. J Immunol Res 2015:627125","journal-title":"J Immunol Res"},{"issue":"1","key":"88_CR36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.taap.2015.05.017","volume":"287","author":"IJ Kosten","year":"2015","unstructured":"Kosten IJ et al (2015b) MUTZ-3 derived Langerhans cells in human skin equivalents show differential migration and phenotypic plasticity after allergen or irritant exposure. Toxicol Appl Pharmacol 287(1):35\u201342","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"88_CR37","first-page":"423","volume":"33","author":"IJ Kosten","year":"2016","unstructured":"Kosten IJ et al (2016) MUTZ-3 Langerhans cell maturation and CXCL12 independent migration in reconstructed human gingiva. Altex 33(4):423\u2013434","journal-title":"Altex"},{"issue":"2","key":"88_CR38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10544-017-0156-5","volume":"19","author":"S Lee","year":"2017","unstructured":"Lee S et al (2017) Construction of 3D multicellular microfluidic chip for an in vitro skin model. Biomed Microdevices 19(2):22","journal-title":"Biomed Microdevices"},{"issue":"6","key":"88_CR39","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/026119290303100604","volume":"31","author":"CL Lehe","year":"2003","unstructured":"Lehe CL et al (2003) A two-centre evaluation of the human organotypic skin explant culture model for screening contact allergens. Altern Lab Anim 31(6):553\u2013561","journal-title":"Altern Lab Anim"},{"issue":"2","key":"88_CR40","first-page":"114","volume":"6","author":"IW Mak","year":"2014","unstructured":"Mak IW, Evaniew N, Ghert M (2014) Lost in translation: animal models and clinical trials in cancer treatment. Am J Transl Res 6(2):114\u2013118","journal-title":"Am J Transl Res"},{"issue":"5","key":"88_CR41","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/sj.jid.5700230","volume":"126","author":"C Marionnet","year":"2006","unstructured":"Marionnet C et al (2006) Interactions between fibroblasts and keratinocytes in morphogenesis of dermal epidermal junction in a model of reconstructed skin. J Invest Dermatol 126(5):971\u2013979","journal-title":"J Invest Dermatol"},{"issue":"3","key":"88_CR42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.toxlet.2006.01.005","volume":"164","author":"V Martinez","year":"2006","unstructured":"Martinez V et al (2006) Evaluation of eye and skin irritation of arginine-derivative surfactants using different in vitro endpoints as alternatives to the in vivo assays. Toxicol Lett 164(3):259\u2013267","journal-title":"Toxicol Lett"},{"key":"88_CR43","doi-asserted-by":"crossref","unstructured":"Maschmeyer I, et al (2015) Chip-based human liver-intestine and liver-skin co-cultures\u2014a first step toward systemic repeated dose substance testing in vitro. Eur J Pharm Biopharm 95(Pt A):77\u201387","DOI":"10.1016\/j.ejpb.2015.03.002"},{"issue":"12","key":"88_CR44","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1039\/C5LC00392J","volume":"15","author":"I Maschmeyer","year":"2015","unstructured":"Maschmeyer I et al (2015) A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. Lab Chip 15(12):2688\u20132699","journal-title":"Lab Chip"},{"issue":"2","key":"88_CR45","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1182\/blood.V100.2.701","volume":"100","author":"AJ Masterson","year":"2002","unstructured":"Masterson AJ et al (2002) MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors. Blood 100(2):701\u2013703","journal-title":"Blood"},{"issue":"4","key":"88_CR46","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/15569527.2012.667031","volume":"31","author":"JM McKim","year":"2012","unstructured":"McKim JM, Keller DJ, Gorski JR (2012) An in vitro method for detecting chemical sensitization using human reconstructed skin models and its applicability to cosmetic, pharmaceutical, and medical device safety testing. Cutan Ocular Toxicol 31(4):292\u2013305","journal-title":"Cutan Ocular Toxicol"},{"key":"88_CR47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tiv.2016.07.010","volume":"36","author":"M Morales","year":"2016","unstructured":"Morales M et al (2016) Evaluation of fibrin-based dermal-epidermal organotypic cultures for in vitro skin corrosion and irritation testing of chemicals according to OECD TG 431 and 439. Toxicol In Vitro 36:89\u201396","journal-title":"Toxicol In Vitro"},{"key":"88_CR48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.biomaterials.2016.11.031","volume":"116","author":"N Mori","year":"2017","unstructured":"Mori N, Morimoto Y, Takeuchi S (2017) Skin integrated with perfusable vascular channels on a chip. Biomaterials 116:48\u201356","journal-title":"Biomaterials"},{"issue":"12","key":"88_CR49","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1021\/tx1002707","volume":"23","author":"A Natsch","year":"2010","unstructured":"Natsch A et al (2010) Chemical basis for the extreme skin sensitization potency of (E)-4-(ethoxymethylene)-2-phenyloxazol-5(4H)-one. Chem Res Toxicol 23(12):1913\u20131920","journal-title":"Chem Res Toxicol"},{"issue":"2","key":"88_CR50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejpb.2005.03.004","volume":"60","author":"F Netzlaff","year":"2005","unstructured":"Netzlaff F et al (2005) The human epidermis models EpiSkin, SkinEthic and EpiDerm: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport. Eur J Pharm Biopharm 60(2):167\u2013178","journal-title":"Eur J Pharm Biopharm"},{"key":"88_CR01","unstructured":"OECD (2012) OECD series on testing and assessment no. 168: the adverse outcome pathway for skin sensitisation initiated by covalent binding to proteins. Part 1: Scientific evidence. Part 2: Use of the AOP to develop chemical categories and integrated assessment and testing approaches. OECD, Paris"},{"issue":"11","key":"88_CR51","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1002\/eji.200838384","volume":"38","author":"K Ouwehand","year":"2008","unstructured":"Ouwehand K et al (2008) CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis. Eur J Immunol 38(11):3050\u20133059","journal-title":"Eur J Immunol"},{"issue":"2","key":"88_CR52","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.tiv.2009.10.014","volume":"24","author":"K Ouwehand","year":"2010","unstructured":"Ouwehand K et al (2010) Comparison of a novel CXCL12\/CCL5 dependent migration assay with CXCL8 secretion and CD86 expression for distinguishing sensitizers from non-sensitizers using MUTZ-3 Langerhans cells. Toxicol In Vitro 24(2):578\u2013585","journal-title":"Toxicol In Vitro"},{"issue":"5","key":"88_CR53","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1189\/jlb.0610374","volume":"90","author":"K Ouwehand","year":"2011","unstructured":"Ouwehand K et al (2011a) Technical advance: langerhans cells derived from a human cell line in a full-thickness skin equivalent undergo allergen-induced maturation and migration. J Leukoc Biol 90(5):1027\u20131033","journal-title":"J Leukoc Biol"},{"issue":"2","key":"88_CR54","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/jid.2010.336","volume":"131","author":"K Ouwehand","year":"2011","unstructured":"Ouwehand K et al (2011b) Irritant-induced migration of Langerhans cells coincides with an IL-10-dependent switch to a macrophage-like phenotype. J Invest Dermatol 131(2):418\u2013425","journal-title":"J Invest Dermatol"},{"key":"88_CR55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tiv.2017.03.010","volume":"42","author":"TDN Pedrosa","year":"2017","unstructured":"Pedrosa TDN et al (2017) A new reconstructed human epidermis for in vitro skin irritation testing. Toxicol In Vitro 42:31\u201337","journal-title":"Toxicol In Vitro"},{"issue":"5","key":"88_CR56","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00018-011-0846-8","volume":"69","author":"M Peiser","year":"2012","unstructured":"Peiser M et al (2012) Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany. Cell Mol Life Sci 69(5):763\u2013781","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"88_CR57","first-page":"337","volume":"149","author":"FHM Pistoor","year":"1996","unstructured":"Pistoor FHM et al (1996) Novel predictive assay for contact allergens using human skin explant cultures. Am J Pathol 149(1):337\u2013343","journal-title":"Am J Pathol"},{"issue":"Suppl 1","key":"88_CR58","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000066682","volume":"15","author":"M Ponec","year":"2002","unstructured":"Ponec M et al (2002) Characterization of reconstructed skin models. Skin Pharmacol Appl Skin Physiol 15(Suppl 1):4\u201317","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"issue":"10","key":"88_CR59","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1039\/C6LC00229C","volume":"16","author":"Q Ramadan","year":"2016","unstructured":"Ramadan Q, Ting FC (2016) In vitro micro-physiological immune-competent model of the human skin. Lab Chip 16(10):1899\u20131908","journal-title":"Lab Chip"},{"issue":"7","key":"88_CR60","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.tiv.2010.07.027","volume":"24","author":"C Rasmussen","year":"2010","unstructured":"Rasmussen C et al (2010) The StrataTest (R) human skin model, a consistent in vitro alternative for toxicological testing. Toxicol In Vitro 24(7):2021\u20132029","journal-title":"Toxicol In Vitro"},{"issue":"1","key":"88_CR61","doi-asserted-by":"crossref","first-page":"25","DOI":"10.14573\/altex.1411011","volume":"32","author":"C Rovida","year":"2015","unstructured":"Rovida C et al (2015) Integrated Testing Strategies (ITS) for safety assessment. Altex 32(1):25\u201340","journal-title":"Altex"},{"issue":"5","key":"88_CR62","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1034\/j.1600-0625.2003.00077.x","volume":"12","author":"T Rustemeyer","year":"2003","unstructured":"Rustemeyer T et al (2003) Comparison of two in vitro dendritic cell maturation models for screening contact sensitizers using a panel of methacrylates. Exp Dermatol 12(5):682\u2013691","journal-title":"Exp Dermatol"},{"issue":"8","key":"88_CR63","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.tiv.2013.08.007","volume":"27","author":"K Saito","year":"2013","unstructured":"Saito K et al (2013) Development of a new in vitro skin sensitization assay (Epidermal Sensitization Assay; EpiSensA) using reconstructed human epidermis. Toxicol In Vitro 27(8):2213\u20132224","journal-title":"Toxicol In Vitro"},{"key":"88_CR64","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tiv.2016.12.005","volume":"40","author":"K Saito","year":"2017","unstructured":"Saito K et al (2017) An in vitro skin sensitization assay termed EpiSensA for broad sets of chemicals including lipophilic chemicals and pre\/pro-haptens. Toxicol In Vitro 40:11\u201325","journal-title":"Toxicol In Vitro"},{"issue":"6","key":"88_CR65","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1189\/jlb.0208092","volume":"84","author":"SJ Santegoets","year":"2008","unstructured":"Santegoets SJ et al (2008) Human dendritic cell line models for DC differentiation and clinical DC vaccination studies. J Leukoc Biol 84(6):1364\u20131373","journal-title":"J Leukoc Biol"},{"issue":"1\u20132","key":"88_CR66","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-5173(00)00665-7","volume":"215","author":"FP Schmook","year":"2001","unstructured":"Schmook FP, Meingassner JG, Billich A (2001) Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int J Pharm 215(1\u20132):51\u201356","journal-title":"Int J Pharm"},{"issue":"9","key":"88_CR67","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1073\/pnas.1222878110","volume":"110","author":"J Seok","year":"2013","unstructured":"Seok J et al (2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 110(9):3507\u20133512","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"88_CR68","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.0906-6705.2005.00226.x","volume":"14","author":"SW Spiekstra","year":"2005","unstructured":"Spiekstra SW et al (2005) Induction of cytokine (interleukin-1alpha and tumor necrosis factor-alpha) and chemokine (CCL20, CCL27, and CXCL8) alarm signals after allergen and irritant exposure. Exp Dermatol 14(2):109\u2013116","journal-title":"Exp Dermatol"},{"issue":"5","key":"88_CR69","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1524-475X.2007.00280.x","volume":"15","author":"SW Spiekstra","year":"2007","unstructured":"Spiekstra SW et al (2007) Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes. Wound Repair Regen 15(5):708\u2013717","journal-title":"Wound Repair Regen"},{"issue":"2","key":"88_CR70","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.tiv.2008.12.010","volume":"23","author":"SW Spiekstra","year":"2009","unstructured":"Spiekstra SW et al (2009) Potential method to determine irritant potency in vitro\u2014comparison of two reconstructed epidermal culture models with different barrier competency. Toxicol In Vitro 23(2):349\u2013355","journal-title":"Toxicol In Vitro"},{"issue":"3","key":"88_CR71","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.tiv.2012.06.004","volume":"27","author":"M Teunis","year":"2013","unstructured":"Teunis M et al (2013) Transfer of a two-tiered keratinocyte assay: IL-18 production by NCTC2544 to determine the skin sensitizing capacity and epidermal equivalent assay to determine sensitizer potency. Toxicol In Vitro 27(3):1135\u20131150","journal-title":"Toxicol In Vitro"},{"issue":"3","key":"88_CR72","first-page":"251","volume":"31","author":"MAT Teunis","year":"2014","unstructured":"Teunis MAT et al (2014) International ring trial of the epidermal equivalent sensitizer potency assay: reproducibility and predictive capacity. Altex-Altern Animal Experimentation 31(3):251\u2013268","journal-title":"Altex-Altern Animal Experimentation"},{"issue":"3","key":"88_CR73","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/jid.2013.417","volume":"134","author":"EH van den Bogaard","year":"2014","unstructured":"van den Bogaard EH et al (2014) Crosstalk between Keratinocytes and T Cells in a 3D Microenvironment: a model to study inflammatory skin diseases. J Invest Dermatol 134(3):719\u2013727","journal-title":"J Invest Dermatol"},{"issue":"4","key":"88_CR74","doi-asserted-by":"crossref","first-page":"389","DOI":"10.14573\/altex.2012.4.389","volume":"29","author":"LJ van den Broek","year":"2012","unstructured":"van den Broek LJ et al (2012) Development, validation and testing of a human tissue engineered hypertrophic scar model. Altex 29(4):389\u2013402","journal-title":"Altex"},{"issue":"3","key":"88_CR75","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12015-017-9737-1","volume":"13","author":"LJ van den Broek","year":"2017","unstructured":"van den Broek LJ et al (2017) Progress and future prospectives in skin-on-chip development with emphasis on the use of different cell types and technical challenges. Stem Cell Rev 13(3):418\u2013429","journal-title":"Stem Cell Rev"},{"issue":"18","key":"88_CR76","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1039\/c3lc50234a","volume":"13","author":"I Wagner","year":"2013","unstructured":"Wagner I et al (2013) A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture. Lab Chip 13(18):3538\u20133547","journal-title":"Lab Chip"},{"issue":"6","key":"88_CR77","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/026119291604400611","volume":"44","author":"RM Walters","year":"2016","unstructured":"Walters RM et al (2016) In vitro assessment of skin irritation potential of surfactant-based formulations by using a 3-D skin reconstructed tissue model and cytokine response. Atla-Altern Lab Animals 44(6):523\u2013532","journal-title":"Atla-Altern Lab Animals"},{"issue":"16","key":"88_CR78","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1177\/1535370217732765","volume":"242","author":"DE Watson","year":"2017","unstructured":"Watson DE, Hunziker R, Wikswo JP (2017) Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology. Exp Biol Med 242(16):1559\u20131572","journal-title":"Exp Biol Med"},{"key":"88_CR79","doi-asserted-by":"crossref","first-page":"37471","DOI":"10.1038\/srep37471","volume":"6","author":"M Wufuer","year":"2016","unstructured":"Wufuer M et al (2016) Skin-on-a-chip model simulating inflammation, edema and drug-based treatment. Sci Rep 6:37471","journal-title":"Sci Rep"}],"container-title":["Current Topics in Microbiology and Immunology","Three Dimensional Human Organotypic Models for Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2018_88","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T12:15:51Z","timestamp":1621512951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2018_88"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783030624514","9783030624521"],"references-count":80,"URL":"https:\/\/doi.org\/10.1007\/82_2018_88","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"23 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}